JPRN-UMIN000019399已完成未知
Prospective study of Sofosbuvir/Ribavirin for HCV genotype 2 infected Japanese patients - IFN free SR study
Osaka City University and affiliated hospitals0 个研究点目标入组 250 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant women Decompensated cirrhosis Hepatocellular carcinoma Renal impairment (eGFR<30) Doctors judge as inappropriate
研究者
相似试验
招募中
不适用
Clinical Trial of Sofosbuvir/Ribavirin for HCV Genotype 2-infected Japanese PatientsChronic hepatitis C (genotype 2)JPRN-UMIN000018554Gunma University and affiliated hospitals50
招募中
不适用
Efficacy and safety of sofosbuvir and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000017703Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
已完成
不适用
Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir FailureHCV CoinfectionNCT03549832Assiut University40
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
已完成
不适用
Efficacy of sofosbuvir and ribavirin therapy in patients with genotype 2 hepatitis C virus: Significance of variants associated with resistance in NS3, NS5A and NS5B regiothe patients infected with genotype 2 HCV who received combination therapy with sofosbvir and rivabirin.JPRN-UMIN000018089Department of Gastroenterology & Hepatology, Saitama Medical University40